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ABSTRACT 
This prospective 6-week study examined the differences in dosage and steady state plasma 
concentrations of sertraline in Chinese versus Caucasian depressed patients. Two groups of 
Chinese patients from different geographical sites and a group of Caucasian patients were 
evaluated with clinical measures during an initial dose of 50 mg/day, with subsequent doses 
adjusted clinically. The results of 17 Australian Chinese (ACHI), 13 Malaysian Chinese 
(MCHI) and 15 Australian Caucasians (AC) were analysed. Despite controlling for weight, 
the AC subjects received a significantly higher dose than both the ACHI (P=0.002) and the 
MCHI groups (P=0.012). However, the mean sertraline concentration to dose ratios at weeks 
1 and 6 were not significantly different between the three groups. Sertraline was effective and 
well tolerated in both ethnic groups with few adverse events. Although there was a lack of 
difference between groups in the pharmacokinetic results, Chinese depressed patients 
appeared to require lower dosages with consequently lower plasma concentrations of 
sertraline compared to Caucasian patients to achieve clinical efficacy. Further studies of the 
dosages, kinetics and adverse effects of selective serotonin reuptake inhibitors linked with 
genotyping are necessary. 
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